PHATHOM PHARMACEUTICALS, INC. (PHAT) Social Stream



PHATHOM PHARMACEUTICALS, INC. (PHAT): $10.68

0.21 (-1.93%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

F

Add PHAT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#360 of 360

in industry

PHATHOM PHARMACEUTICALS INC (PHAT) Price Targets From Analysts

Use the tables below to see what analysts covering PHATHOM PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 2 $59 $59 $59 $7.68 668.23%
2022-05-10 2 $48 $48 $48 $7.68 525%
2022-05-24 3 $15 $15 $15 $7.68 95.31%
2022-08-03 3 $45 $9 $30.666 $7.68 299.3%
2022-10-21 4 $45 $9 $27 $7.68 251.56%
2022-11-11 6 $45 $9 $27.6 $7.68 259.38%
2022-11-14 6 $38 $9 $26.2 $7.68 241.15%
2023-01-04 6 $35 $9 $22.6 $7.68 194.27%
2023-02-10 6 $35 $9 $22.2 $7.68 189.06%
2023-03-01 6 $30 $9 $21.2 $7.68 176.04%
2023-04-19 6 $30 $9 $21.166 $7.68 175.6%
2023-05-11 6 $30 $9 $19.6 $7.68 155.21%
2023-08-11 6 $30 $20 $24.4 $7.68 217.71%
2023-11-10 6 $28 $20 $23 $7.68 199.48%
2023-11-28 7 $28 $9 $20.666 $7.68 169.09%

The Trend in the Analyst Price Target


Over the past 29 months, PHAT's average price target has gone down $37.5.

Over the past 42 weeks, PHAT's average upside potential has been 113.95%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-19 7 30 9 21.166 10.72 97.44%
2023-05-11 6 30 9 19.600 13.19 48.6%
2023-05-11 5 30 9 21.333 13.19 61.74%
2023-05-11 5 30 15 22.250 13.19 68.69%
2023-10-10 6 28 20 23.000 10.71 114.75%

PHAT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.43 5 1 1 0 0 7

The Trend in the Broker Recommendations


PHAT's average broker recommendation rating improved by 0.28 over the prior 31 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PHAT as an investment opportunity.

  • In the context of all US stocks, PHATHOM PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 2765.61% of them.
  • In terms of how PHATHOM PHARMACEUTICALS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1593.56% of that group.
  • In terms of how PHATHOM PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 570.73% of that group.
  • PHAT has a higher average analyst price target than 2169.24% of stocks in the small market cap category.

In the Pharmaceutical Products industry, TFFP, PROC, and THTX are the three stocks most similar to PHATHOM PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for PHAT? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!